AU Patent

AU2016284162A1 — Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)acetic acid(Compound1) for use in SIP1 receptor-associated disorders

Assigned to Arena Pharmaceuticals Inc · Expires 2018-02-01 · 8y expired

What this patent protects

The present invention relates to, inter

USPTO Abstract

The present invention relates to, inter

Drugs covered by this patent

Patent Metadata

Patent number
AU2016284162A1
Jurisdiction
AU
Classification
—
Expires
2018-02-01
Drug substance claim
No
Drug product claim
No
Assignee
Arena Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.